![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-29-2023-18805.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205643
https://www.fiercepharma.com/pharma/specialty-injectables-maker-exela-issues-recall-after-particles-turn-3-different-drugs
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/exela-pharma-sciences-llc-issues-voluntary-nationwide-recall-84-sodium-bicarbonate-injection-usp-50
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-21-2022-3491.pdf
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/exela-pharma-sciences-llc-expands-voluntary-nationwide-recall-sodium-bicarbonate-injection-usp-84-50
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-2-2022-77418.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212071
https://www.fiercepharma.com/manufacturing/contents-under-pressure-exela-recalls-49-lots-metabolic-acidosis-injection-over-fear
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/exela-pharma-sciences-llc-issues-voluntary-nationwide-recall-sodium-bicarbonate-injection-usp-84-50